PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. (Q2906826): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in it: Adding Italian translations) |
(Changed label, description and/or aliases in es: Adding Spanish translations) |
||
| label / es | label / es | ||
PEMDOTLS.: Evaluación preclínica de derivados de la miltefosina optimizado para el tratamiento de la leishmaniosis y la enfermedad del sueño. | |||
Revision as of 08:13, 21 January 2022
Project Q2906826 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PEMDOTLS: Preclinical evaluation of Miltefosin derivatives optimised for the treatment of Leishmaniasis and Sleep Disease. |
Project Q2906826 in Portugal |
Statements
204,000.0 Euro
0 references
240,000.0 Euro
0 references
85.0 percent
0 references
26 July 2018
0 references
25 July 2022
0 references
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR - IBMC
0 references
Q2985732 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-031013
0 references